Video | April 30, 2020

When COVID-19 Presses Your Company To Make An R&D Pivot

Source: Life Science Leader

Rob Wright, chief editor of Life Science Leader, recently conducted a COVID-19 leadership roundtable with five biopharmaceutical CEOs via Zoom (view in full here). In this portion, Rachel Leheny, Ph.D., CEO of CalciMedica, discusses how her company, which had been studying an investigational compound (CM4620-IE) for patients with acute pancreatitis, pivoted and gained FDA approval to investigate if the compound could help patients suffering from COVID-19.